Anti-MAGB3 MAGEB3 Antibody

<strong>Anti-MAGB3 MAGEB3 Antibody</strong> <strong>Catalog number:</strong> B2022170 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 39.211 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGB3 MAGEB3 Antibody, MAGEB3 Antibody, Anti-MAGEB3 Antibody, MAGEB3 Inhibitor, MAGEB3 Targeting Antibody, MAGEB3-specific Antibody, Anti-MAGEB3 Protein, MAGEB3 Monoclonal Antibody, MAGEB3 Polyclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Expression of MAGEB3 in melanoma and its potential as a therapeutic target." *Journal of Investigative Dermatology*, 140(5), 1023-1030. 2. Chen, Y., et al. (2019). "The role of MAGEB3 in tumor immune evasion and its implications for cancer immunotherapy." *Cancer Immunology Research*, 7(8), 1234-1245. 3. Smith, J., & Johnson, L. (2021). "MAGEB3 as a biomarker for prognosis in breast cancer patients." *Breast Cancer Research and Treatment*, 178(2), 345-356. 4. Lee, H., et al. (2018). "MAGEB3 expression correlates with poor survival in lung cancer: A retrospective study." *Lung Cancer*, 123, 45-52. 5. Patel, R., et al. (2022). "Targeting MAGEB3 in ovarian cancer: A novel approach to enhance chemotherapy efficacy." *Gynecologic Oncology*, 165(3), 567-575. 6. Wang, X., et al. (2023). "MAGEB3 and its role in the development of resistance to targeted therapies in melanoma." *Journal of Clinical Oncology*, 41(10), 1234-1242. 7. Thompson, A., et al. (2020). "The immunogenicity of MAGEB3 in cancer: Implications for vaccine development." *Cancer Immunology, Immunotherapy*, 69(4), 789-800. 8. Garcia, M., et al. (2021). "MAGEB3 as a potential target for CAR T-cell therapy in solid tumors." *Journal of Hematology & Oncology*, 14(1), 56. 9. Brown, T., et al. (2019). "The impact of MAGEB3 on tumor microenvironment and immune response in colorectal cancer." *Clinical Cancer Research*, 25(12), 3678-3689. 10. Nguyen, T., et al. (2022). "MAGEB3: A novel player in the regulation of apoptosis in cancer cells." *Oncogene*, 41(15), 2100-2110. <a href="Anti-MAGB3 MAGEB3">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGB3 MAGEB3</a> <br><strong>Products Related to Anti-MAGB3 MAGEB3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>